My Research Webinar – New Models of Care

The BOPA Research Subcommittee would like to invite you to one of our live webinar sessions on “New Models of Care”.

 

Webinar Schedule:

Airedale NHS Foundation Trust secured NHSE Invest to Save funding and employed two part-time pharmacists to reduce wastage and expenditure of cancer chemotherapy – Emma Makram (25mins)

Utilising the NHSE SACT waste calculator to assess the level of waste – Experience at Calderdale and Huddersfield NHS Trust (CHFT) and Mid Yorkshire Teaching Trust – Louise Hemmings (25 mins)

Q&A (10mins)

 

When: 23rd April 2025, 13:00 – 14:00 BST

 

Register: Click HERE for more information and HERE to register

 

Registration is FREE for all BOPA Members and Associates!
Click here to join BOPA.

Speaker Profile:

Emma Makram is a Specialist Clinical Pharmacist in Cancer Services Medicines Optimisation at Airedale NHS Foundation Trust. She has worked in this role as a job share since 2023 as part of the NHSE Invest to Save Initiative. In this role, Emma has been involved in several projects to make savings and reduce SACT waste. 

Since qualifying as a pharmacist in 2011, Emma has worked in community pharmacy in the North West of England before moving to hospital pharmacy via bank roles at The Christie Clinic and Airedale. She has worked at Airedale in various clinical roles since 2016.

 

Louise Hemmings is an Advanced Clinical Pharmacist in Cancer Services working at Calderdale and Huddersfield NHS Trust. From September 2023 to September 2024 she undertook a secondment to work with NHSE as part of an Invest to Save Initiative specifically looking at SACT Waste across Calderdale and Huddersfield NHS Trust and Mid Yorkshire Teaching Trust. She completed her MPharm at the University of Bradford and a post graduate clinical pharmacy diploma at the University of Cardiff. Since qualifying 15 years ago she has worked as an admissions pharmacist, antimicrobial pharmacist and in HIV and Sexual Health services at a number of different trusts in the Yorkshire region, before moving into Cancer Services.

 

Register for your free place now via the link above. We look forward to welcoming you all.

Best Wishes
BOPA Research Subcommittee

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article